Medicines and
Health Technologies

The main goal of the area of ​​Medicines and Health Technologies is to strengthen the Medicines Policy of the region, developing, together with different actors and organizations, strategies that ensure the access to medicines and the sustainability of health systems.


Work Topics

– Intellectual property
– Drug prices
– Technology Assessment

Ángela Acosta

Ángela Acosta

Graduated in Chemistry-Pharmacy from the National University of Colombia, she holds a Master’s Degree in Clinical and Sanitary Effectiveness from the University of Buenos Aires and holds a PhD in Pharmaceutical-epidemiology from the same institution. With 15 years’ experience, he has been a leader and advisor at the Ministry of Health and Social Protection of Colombia, at INVIMA (National Institute for Drug and Food Surveillance) and several projects for PAHO/WHO and the World Bank.



The 2018 Annual Operative Plan of ISAGS is under way

Every year, ISAGS submits to its Directing Council the work proposals for the following year. It’s the so-called Annual Operative Plan (POA 2018), which gathers and systematizes the main initiatives that will be carried out by the Institute’s different areas of action. “After an excellent year of activities and a good regional positioning in 2017, […]


The Mapping of Productive Capacity of Medicines and Health Supplies of the South American Region was launched

As the Executing Entity of the project, ISAGS will support GAUMU for the successful implementation of the project, which is of great relevance to the South American region in its drive to count as Universal Health Systems, recognizing health as a fundamental right of its population.


Regulation of Prices of Medicines in South America: Results and Concrete Strategies of Colombia

In general, medicines are an important component of health spending. Data on total pharmaceutical expenditure confirms that medicines have an important share in the total health expenditure, while this proportion varies considerably between low- and high-income countries, from a 19.7% participation in high income countries to a 30.4% in low-income countries (WHO 2011). The pharmaceutical […]


Balance of the UNASUR Health Week

Brief account of four key days for South American health: the approval of the Medicines Price Bank, the expansion of the food labelling policy, the unanimous criticism of the pharmaceutical industry‘s speculation regarding hepatitis C and the launch of ISAGS monthly journal: Health to the South. Never before had the General Secretariat of UNASUR hosted […]


TERMS OF REFERENCE – consultancy services for mapping of production capacities of medicines

The joint project is framed within the GAUMU&8216;s Five-Year Plan 2010-2015


UNASUR opens workshop for the development of the medicine price database

The idea of the Price Database is to create a network for the exchange of information about procurement, which would facilitate decision-making for public managers and guarantee the full access to medicines for the South American people